Investigation into conolidine has brought about discovery of an opioid receptor in your body identified as ACKR3/CXCR7. ACKR3 appears to be the most popular target for conolidine, which also disregards one other four classical opioid receptors(3). This can be rising to be a promising alternative drug. Far more importantly, https://williamk331hln5.blog5star.com/profile